Virtuix Holdings Inc. is a developer of AI-driven, full-body immersive simulation systems and the creator of the "Omni" omni-directional treadmill, which lets users physically walk and move through virtual and AI-generated environments. The company's product lineup includes Omni One, Omni Pro, Omni Arena, and the Virtual Terrain Walk system, spanning consumer entertainment, defense training and simulation, robotics, healthcare, research, and enterprise applications.
Headquartered in Austin, Texas, Virtuix has built a customer and partner network that includes META, NASA, TSLA, KBR, and Sirica Therapeutics, alongside deployments and research initiatives with the U.S. Army, Marine Corps, Navy, and Air Force. I follow VTIX closely because of its transition from an entertainment-focused hardware maker into a broader full-body simulation platform targeting high-value government and enterprise markets. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, VTIX has declined approximately 30%, moving from a closing price of about $0.84 to roughly $0.59. The move has been part of a sustained downtrend rather than a single-day shock, with the shares drifting lower through late October and early November before a modest rebound in recent sessions.
The quarterly picture is even steeper. From a level near $1.70 in mid-August, the stock has fallen roughly 65%. This reflects a multi-month pattern of lower highs and lower lows, with selling pressure persisting even as the company announced a series of positive commercial milestones.
Virtuix's recent share-price weakness stands in contrast to its operational headlines. During the period, the company became an official reseller of Meta products and reported that Omni One orders had tripled following the launch of Omni One for Quest. It also announced a sale to the U.S. Army's National Simulation Center, secured its 27th U.S. patent, and signed a non-binding letter of intent to acquire defense contractor STS International, which reported approximately $40 million in unaudited cash-basis revenue through October 2026.
Despite these announcements, the stock continued to fall, suggesting that investors are focused on near-term financial realities rather than growth narratives. The company has yet to reach profitability, continues to generate negative operating cash flow, and faces financing requirements tied to the proposed STS International acquisition, for which no committed financing has yet been secured. Combined with a micro-cap valuation and limited liquidity, these factors have kept sustained downward pressure on the share price.
The broader three-month decline reflects a market repricing of an early-stage, loss-making company. After a period of elevated trading around its Nasdaq listing and initial post-listing volatility, VTIX shares have gradually de-rated as investors weighed continued cash burn against the company's still-nascent revenue scale, with trailing twelve-month revenue around $4 million against a wider net loss.
At the same time, the company's fundamentals have been moving forward. The June launch of Omni One for Quest in collaboration with Meta drove a reported tripling of orders, and Virtuix's defense footprint expanded across multiple branches of the U.S. military. The gap between improving commercial momentum and a falling share price highlights the tension between long-term growth potential and short-term liquidity and profitability concerns.
Several factors are likely to shape VTIX's near-term trajectory. First, the company's fiscal second-quarter results, scheduled for the November 16, 2026 earnings call, will provide clarity on whether the Meta-driven order surge translated into actual revenue and margin improvement. Second, the outcome of the proposed STS International acquisition — including financing terms, due diligence, and closing conditions — will be closely watched, given the potential step-change in revenue and the associated dilution and execution risks.
Investors should also monitor continued gross-margin progress, cash runway, and any new defense or enterprise contracts. Macroeconomic conditions and sentiment toward small-cap and speculative technology names may add further volatility. These developments carry both opportunity and risk, and the company's ability to convert order momentum into sustainable profitability remains the central question.
In my regular research process, I turn to Tickeron’s AI Trading Bots to test automated strategies across volatile names like VTIX. The platform offers hundreds of bots with different timeframes and approaches, and reviewing the trending performers helps me quickly spot ideas that align with current market conditions. It has become a practical way to add quantitative context without replacing my own fundamental work.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where VTIX advanced for three days, in 27 of 36 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 21 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 8 of 12 cases where VTIX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on VTIX as a result. In 9 of 13 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for VTIX just turned positive on November 06, 2026. Looking at past instances where VTIX's MACD turned positive, the stock continued to rise in 3 of 5 cases over the following month. The odds of a continued upward trend are 60%.
VTIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for VTIX entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-5.932) is normal, around the industry mean (-6.197). P/E Ratio (-0.817) is within average values for comparable stocks, (-3.670). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (23.994). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (8.230) is also within normal values, averaging (51.774).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. VTIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VTIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerProcessingHardware